Windlas Biotech Ltd
NSE: WINDLAS BSE: 543329
₹923.40
+6.10 (0.66%)
Sat, 24 Oct 2026, 02:54 am
Market Cap (in Cr)1893.99
PE Ratio29.54
Dividend0.69
Health Technology
Pharmaceuticals: Major
24.5KWindlas Biotech Balance Sheet
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Interest expense on debt | -64.68M | -48.38M | -25.26M | -12.90M | -14.17M | -7.88M | -11.05M | -43.82M |
| Pretax equity in earnings | — | — | — | — | 0 | 0 | 0 | 0 |
| Equity in earnings | 1.24M | -7.67M | -74.66M | -1.73M | 0 | 0 | 0 | 0 |
| Total assets | 2.90B | 2.98B | 3.38B | 2.96B | 4.92B | 5.32B | 6.30B | 7.66B |
| Total current assets | 1.44B | 1.20B | 1.68B | 1.94B | 3.82B | 3.54B | 4.31B | 5.25B |
| Cash and short term investments | 300.48M | 340.96M | 406.64M | 542.55M | 1.79B | 1.32B | 2.04B | 2.39B |
| Cash & equivalents | 71.95M | 128.55M | 180.78M | 159.30M | 31.91M | 36.86M | 53.06M | 4.46M |
| Short term investments | 228.53M | 212.41M | 225.86M | 383.25M | 1.75B | 1.28B | 1.99B | 2.39B |
| Total receivables, net | 666.40M | 618.26M | 640.33M | 798.64M | 1.13B | 1.17B | 1.37B | 1.67B |
| Accounts receivable - trade, net | 665.91M | 617.35M | 639.38M | 794.13M | 1.11B | 1.17B | 1.36B | 1.67B |
| Other receivables | 490.00K | 910.00K | 950.00K | 4.51M | 22.30M | 4.92M | 7.49M | 6.32M |
| Total inventory | 351.81M | 196.45M | 501.71M | 430.00M | 613.29M | 762.01M | 631.76M | 832.66M |
| Other current assets, total | 115.64M | 46.17M | 127.63M | 160.83M | 277.19M | 271.44M | 257.20M | 340.18M |
| Total non-current assets | 1.46B | 1.78B | 1.70B | 1.02B | 1.11B | 1.78B | 1.99B | 2.41B |
| Long term investments | 28.51M | 1.04B | 963.78M | 29.85M | 25.66M | 58.18M | 20.00M | 9.80M |
| Note receivable - long term | 24.99M | 21.06M | 22.44M | 29.85M | 50.00K | 0 | 210.00K | 80.00K |
| Investments in unconsolidated subsidiaries | 1.88M | 1.01B | 940.01M | 0 | 0 | 0 | 0 | 0 |
| Other investments | 1.64M | 1.84M | 1.33M | 0 | 25.61M | 58.18M | 19.79M | 9.72M |
| Net property/plant/equipment | 940.69M | 704.52M | 700.64M | 956.68M | 984.68M | 1.61B | 1.85B | 2.24B |
| Gross property/plant/equipment | 1.10B | 892.43M | 782.20M | 1.52B | 1.66B | 2.40B | 2.75B | 3.37B |
| Deferred tax assets | 7.44M | 5.08M | 6.63M | 0 | 32.00M | 48.00M | 42.09M | 55.46M |
| Net intangible assets | 454.85M | 4.42M | 5.52M | 4.82M | 8.82M | 14.84M | 44.68M | 67.79M |
| Goodwill, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other intangibles, net | 454.85M | 4.42M | 5.52M | 4.82M | 8.82M | 14.84M | 44.68M | 67.79M |
| Other long term assets, total | 27.86M | 25.77M | 28.02M | 26.77M | 52.35M | 45.41M | 26.91M | 35.76M |
| Short term debt | 373.65M | 245.25M | 266.88M | 310.00M | 61.93M | 18.67M | 16.23M | 303.46M |
| Current portion of LT debt and capital leases | 134.60M | 74.46M | 57.43M | 15.95M | 8.80M | 18.67M | 16.23M | 32.29M |
| Short term debt excl. current portion of LT debt | 239.05M | 170.79M | 209.45M | 294.05M | 53.13M | 0 | 0 | 271.17M |
| Accounts payable | 846.17M | 579.34M | 831.36M | 399.33M | 632.32M | 877.43M | 1.32B | 1.67B |
| Income tax payable | 48.76M | 39.96M | 0 | 0 | — | 5.91M | 0 | — |
| Long term debt | 200.68M | 73.21M | 22.46M | 13.49M | 4.44M | 31.26M | 20.18M | 22.51M |
| Long term debt excl. lease liabilities | 200.68M | 73.21M | 22.46M | 13.49M | 4.44M | 31.26M | 20.18M | 22.51M |
| Total equity | 1.25B | 1.94B | 2.10B | 1.99B | 3.95B | 4.02B | 4.50B | 5.06B |
| Shareholders' equity | 1.25B | 1.94B | 2.10B | 1.99B | 3.95B | 4.02B | 4.50B | 5.06B |
| Common equity, total | 1.22B | 1.94B | 2.10B | 1.99B | 3.95B | 4.02B | 4.50B | 5.06B |
| Other common equity | 139.10M | 136.25M | 136.25M | 136.22M | 154.32M | 168.44M | 189.70M | 214.24M |
| Total debt | 574.33M | 318.46M | 289.34M | 323.49M | 66.37M | 49.93M | 36.41M | 325.97M |
| Net debt | 273.85M | -22.50M | -117.30M | -219.06M | -1.72B | -1.27B | -2.01B | -2.07B |
| Change in accounts receivable | -8.23M | -9.75M | -26.06M | -148.35M | -316.73M | -83.63M | -198.35M | -308.03M |
| Change in taxes payable | — | — | — | — | — | — | — | — |
| Change in accounts payable | -10.76M | -247.42M | 252.00M | -460.39M | 233.04M | 245.12M | 437.68M | 357.26M |
| Change in other assets/liabilities | -133.87M | 37.16M | 41.65M | 107.65M | -119.50M | 61.99M | 74.71M | 51.80M |
| Sale of fixed assets & businesses | 6.11M | 700.00K | 140.00K | 150.00K | 1.10M | 9.10M | 420.00K | 1.97M |
| Purchase/sale of investments, net | 137.83M | 31.29M | 360.00K | 834.13M | -1.42B | 513.20M | -561.67M | -236.94M |
| Sale/maturity of investments | 137.83M | 31.29M | 360.00K | 1.02B | 0 | 882.28M | — | — |
| Purchase of investments | 0 | 0 | 0 | -188.02M | -1.42B | -369.08M | -561.67M | -236.94M |
| Other investing cash flow items, total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of debt, net | -200.12M | -56.99M | -24.81M | 38.85M | -251.95M | -56.77M | -3.35M | 270.08M |
| Issuance/retirement of long term debt | -86.93M | -13.47M | -63.47M | -45.75M | -3.88M | -3.35M | -1.09M | 0 |
| Issuance/retirement of short term debt | -113.19M | -43.52M | 38.66M | 84.60M | -248.07M | -53.42M | -2.26M | 270.08M |
| Issuance/retirement of other debt | — | — | — | — | — | — | — | — |
| Total cash dividends paid | 0 | 0 | 0 | 0 | 0 | -76.28M | -83.01M | -114.95M |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
